300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Payments
Photography
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Crowdfunding
Theatre
Recruiting
Web3
Medical
Venture Capital
Fashion
Beauty
Social
Infrastructure
LGBT
Cannabis
Climate
Celebrity
Mobile Apps
Wine and Spirits
Food and Beverage
Publishing
Life Science
Music
Sporting Goods
Real Estate
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Kazakhstan
Cayman Islands
Venezuela
Switzerland
Myanmar
Uganda
Guatemala
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Estonia
Ecuador
Bolivia
Belize
Faroe Islands
Jersey
Algeria
Bahrain
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Bahamas
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Israel (September 2026)

The most active venture capital funds investing in Israel Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Israel Medical startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
OurCrowd
VC Fund
16 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $604k–$65M
Pontifax
VC Fund
11 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.3M–$130M
Israel Innovation Authority
VC Fund
10 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Artificial Intelligence, Biotechnology $100k–$6M
Trendlines Group
VC Fund
9 Israel, Singapore, United Kingdom Seed, Venture - Series Unknown Health Care, Biotechnology, Medical Device $650k–$62M
Triventures
VC Fund
6 United States, Israel, Ireland Series A, Series B Health Care, Medical Device, Medical $6M–$28M
HBL Hadasit Bio Holdings
VC Fund
6 Israel Venture - Series Unknown, Seed, Series A Biotechnology, Medical, Health Care $10M–$47M
Vertex Ventures Israel
VC Fund
4 Israel, United States, Canada Series A, Series B, Series C Software, Information Technology, Artificial Intelligence $3.5M–$100M
S2G Investments
VC Fund
4 United States, Canada, Israel Series A, Series B, Venture - Series Unknown Food and Beverage, Agriculture, Biotechnology $3.9M–$100M
Agriline
VC Fund
4 Israel Seed, Series A, Venture - Series Unknown Health Care, Medical, Biotechnology $1.3M–$17M
Btomorrow Ventures
VC Fund
4 United States, United Kingdom, India Series A, Seed, Series B Health Care, Wellness, Food and Beverage
Cybele Holdings
VC Fund
4 Israel, United States, Cyprus Post-IPO Equity, Venture - Series Unknown, Series D Health Care, Real Estate, Biotechnology $519k–$98M
Docor International Management
VC Fund
4 Israel, United States Series C, Venture - Series Unknown Health Care, Biotechnology, Medical Device $8M–$22M
aMoon Fund
VC Fund
4 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
Terra Venture Partners
VC Fund
3 Israel, United States Seed, Series A, Series B Software, Health Care, Machine Learning $1M–$30M
Robin Hood Ventures
VC Fund
3 United States, Canada, Israel Seed, Series A, Convertible Note Software, Health Care, Biotechnology $26k–$11M
ALIVE Israel HealthTech Fund
VC Fund
3 Israel, United States Series A, Series C, Venture - Series Unknown Health Care, Medical, Biotechnology $4.4M–$105M
Neo Ventures
VC Fund
3 United States, United Kingdom, Israel Seed, Series A Software, Artificial Intelligence, SaaS $500k–$24M
Clal Biotechnology Industries
VC Fund
3 Israel, United States Series A, Series B Health Care, Biotechnology, Medical Device $4M–$55M
OrbiMed
VC Fund
3 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $9.8M–$160M
Elron Ventures
VC Fund
3 Israel, United States, China Series A, Seed Information Technology, Software, Cyber Security $1M–$17M
TechWald Holding S.p.A.
VC Fund
3 Israel, United States, Switzerland Series A, Series B, Series C Health Care, Medical Device, Medical $3.6M–$60M
Qure Ventures
VC Fund
3 United States, Israel Series A, Series B, Series C Health Care, Medical Device, Medical $8.8M–$20M
MTIP AG
VC Fund
3 United States, United Kingdom, Spain Series A, Series B, Series C Health Care, Medical, Artificial Intelligence $1.5M–$80M
Insight Partners
VC Fund
3 United States, Israel, Germany Series B, Series A, Series C Software, Information Technology, SaaS $12M–$140M
ShengJing360
VC Fund
3 China, Israel, Malaysia Series A, Series B, Seed Artificial Intelligence, Manufacturing, Biotechnology $1.9M–$42M
Alon Medtech Ventures
VC Fund
3 Israel Seed, Series B, Corporate Round Medical, Health Care, Medical Device $900k–$2.2M
Mindset Ventures
VC Fund
3 United States, Israel, Canada Series A, Seed, Series B Software, Artificial Intelligence, Machine Learning $1.9M–$35M
EISMEA
VC Fund
3 Spain, Italy, United Kingdom Grant, Venture - Series Unknown, Seed Manufacturing, Biotechnology, Software $52k–$2.6M
XTX Ventures
VC Fund
3 United Kingdom, United States, Israel Series A, Seed Artificial Intelligence, Software, Machine Learning $2M–$60M
Connecticut Innovations
VC Fund
3 United States, Israel, Canada Seed, Series A Health Care, Biotechnology, Software $150k–$25M
Ziegler Meditech Equity Partners
VC Fund
3 United States, Israel Series C, Series E, Series F Health Care, Biotechnology, Mobile
Technion - Israel Institute of Technology
VC Fund
3 Israel, United States Seed, Grant, Series A Medical, Health Care, Therapeutics $1.2M–$20M
Tal Ventures
VC Fund
3 Israel, United States, Cyprus Seed, Series A, Pre-Seed Software, Artificial Intelligence, SaaS $2.1M–$25M
CE Ventures (CEIIF)
VC Fund
3 Israel, United States, India Series B, Series A, Series C Software, Analytics, Big Data $3.5M–$40M
Entrée Capital
VC Fund
3 United States, Israel, United Kingdom Seed, Series A, Series B Software, FinTech, Financial Services $1.5M–$54M
Alumni Ventures
VC Fund
3 United States, United Kingdom, Canada Seed, Series A, Series B Software, Artificial Intelligence, Information Technology $880k–$75M
Good Company
VC Fund
3 Israel, United States Seed, Pre-Seed, Series A Software, Artificial Intelligence, Recruiting $400k–$22M
DEFTA Partners
VC Fund
2 United States, Israel, Japan Series A, Series B, Venture - Series Unknown Biotechnology, Medical, Software $989k–$47M
fresh.fund
VC Fund
2 Israel, United States, Norway Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $300k–$21M
HealthpointCapital
VC Fund
2 Israel, United States Series B, Series C Medical, Biotechnology, Manufacturing $5M–$15M
Israel Healthcare Ventures
VC Fund
2 Israel, United States Series D, Series F Health Care, Medical Device, Medical $1.2M–$40M
GlenRock Israel
VC Fund
2 Israel, United States Seed, Series A, Series B Software, Health Care, Cyber Security $100k–$30M
Smith & Nephew
VC Fund
2 United States, Israel, United Kingdom Series B, Series C Medical Device, Medical, Health Care $2.7M–$30M
Arc Impact
VC Fund
2 Israel, United States, United Kingdom Seed, Series A, Pre-Seed Health Care, Food and Beverage, Artificial Intelligence $2M–$20M
Group 11
VC Fund
2 United States, Israel Series A, Series B, Seed FinTech, Software, Financial Services $1.5M–$100M
Indaco Venture Partners
VC Fund
2 Italy, United States, United Kingdom Series A, Series B Biotechnology, Health Care, Medical
Binder & Partners Ventures
VC Fund
2 Israel, France, United States Seed, Pre-Seed, Series A Software, Information Technology, Computer $2M–$14M
Flerie Invest
VC Fund
2 Sweden, United States, United Kingdom Series A, Venture - Series Unknown, Series B Biotechnology, Health Care, Pharmaceutical $2.5M–$75M
Rimonci Capital
VC Fund
2 Israel Series A, Series B, Series C Health Care, Medical Device, Medical
Yozma Group
VC Fund
2 Israel, United States, South Korea Series B, Seed Software, Health Care, Medical $400k–$59M
Access all 577 VC funds in Israel Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 16 investments in Israel Medical startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 363
  • Round size: Seed $604k–$9.5M; Series A $4.5M–$22M; Series B $7M–$65M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely actively investing — fresh fund, raised $230k in 2026

Portfolio highlights

  • N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
  • Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
  • MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 11 investments in Israel Medical startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 122
  • Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Otic Pharma — Otic Pharma is a clinical-stage pharmaceutical company focusing on the development and commercialization of products for disorders of the ear, nose, and throat (ENT). The company has two platform technologies, each of which has the potential to be developed for multiple ENT indications. The company is currently developing anasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD), a condition that affects more than 700 million people around the world every year. Otitis media is one of the most common disease seen in pediatric practice and the most frequent reason children consume antibiotics or undergo surgery. The company also has a foam-based drug delivery technology platform (OP-01) that can be used to deliver drugs into the ear, nose, and sinus cavities. The company is currently developing OP-01 as an improved treatment option for acute otitis externa (“swimmers ear”). For more information on the company, please visit www.oticpharma.com
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 10 investments in Israel Medical startups

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 217
  • Round size: Seed $400k–$6M; Grant $130k–$3.5M; Pre-Seed $100k–$2.1M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $10M in 2023

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • PulseNmore — Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
  • GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Show all investments...

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 9 investments in Israel Medical startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Venture - Series Unknown
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Seed $650k–$4.1M; Venture - Series Unknown $1M–$62M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Triventures
VC Fund · Herzliya, Tel Aviv, Israel · 6 investments in Israel Medical startups

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B
  • Geography: United States, Israel, Ireland

Investor stats

  • Total investments: 60
  • Round size: Series A $6M–$24M; Series B $6M–$28M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2015

Portfolio highlights

  • Grin — Grin is a comprehensive digital orthodontic platform providing teeth straightening for all types of patients with a real local orthodontist. The platform also connects patients with a real orthodontist from the convenience of their smart device. They deliver responsible care from orthodontic specialists in an easily accessible and cost-effectiveway, Grin provides patients quality care that results in an exceptional smile together with all of the modernized convenience that they expect.Grin technology, aligned with a network of local trusted orthodontists, ensures that every patient gets the right care. The platform Grin App and Grin Scope is a patent-pending technology that offers remote monitoring for a variety of orthodontic needs. The Grin experience includes high-quality self-scans with the latest teeth straightening solutions. Practitioners and patients can now use these telemedicine tools to achieve a new, more convenient treatment journey.It was founded by Dr. Adam Schulhof, Pamela Oren-Artzi, and Alon Lipnik in 2019 and is based in New York and Austin.
  • Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
  • TailorMed — Moving Mountains for Patients
Show all investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 6 investments in Israel Medical startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 11
  • Round size: Venture - Series Unknown $10M–$47M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

Vertex Ventures Israel
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Israel Medical startups

We partner early with global-minded entrepreneurs seeking to disrupt large markets

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, Canada

Investor stats

  • Total investments: 189
  • Round size: Series A $3.5M–$28M; Series B $5M–$35M; Series C $5.6M–$100M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — raised $170M in 2022

Portfolio highlights

  • Rylo — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
  • Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
  • Quantum Art — Quantum Art develops scalable, multi-core quantum computers with advanced trapped ion qubits and multi-qubit gates, accelerating breakthroughs in AI, finance, and materials science.
Show all investments...

S2G Investments
VC Fund · Chicago, Illinois, United States · 4 investments in Israel Medical startups, 15 in the past 12 months

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 227
  • Round size: Series A $4M–$55M; Series B $3.9M–$100M; Venture - Series Unknown $4.3M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely actively investing — fresh fund, raised $1B in 2026

Portfolio highlights

  • Corvus Robotics — AI-powered autonomous drones and forklift sensors for real-time warehouse inventory visibility. Trusted by Fortune 500 enterprises.
  • SWARM — SWARM is a Software-as-a-Service platform that uses a next generation cognitive computing system, structured around a multi-agent approach which can utilize a cur
  • Kuehnle Agrosystems — Kuehnle AgroSystems curates a unique set of algae originating from pristine waters and ecosystems of Hawaii, as well as tropical botanical accessions representing plants prized by Polynesian voyagers.
Show all investments...

Agriline
VC Fund · Bromsgrove, Worcestershire, United Kingdom · 4 investments in Israel Medical startups

Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Show all investments...

Btomorrow Ventures
VC Fund · London, England, United Kingdom · 4 investments in Israel Medical startups, 6 in the past 12 months

Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.

Show more...

Investment focus

  • Industry: Health Care, Wellness, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 44
  • Lead/follow: no public data

Portfolio highlights

  • Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
  • Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
  • PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Cybele Holdings
VC Fund · Ramat Gan, Tel Aviv, Israel · 4 investments in Israel Medical startups

Cybele Group is a full service consulting and financial services firm, which provides investment banking, brokerage and asset management services to both corporations and a wide array of clients, ranging from individuals and small businesses to the world's largest corporations and governments.

Show more...

Investment focus

  • Industry: Health Care, Real Estate, Biotechnology
  • Stage:Post-IPO Equity, Venture - Series Unknown, Series D
  • Geography: Israel, United States, Cyprus

Investor stats

  • Total investments: 60
  • Round size: Post-IPO Equity $574k–$73M; Venture - Series Unknown $519k–$98M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Silverbyte — Optima is an international, top notch Hotel Management Software solution for medium to high end hotels and groups with over 1000 installations in 34 countries.
  • Cannabotech — Cannabotech develop, and assimilate the medicinal properties of Cannabinoids & Mushrooms, integrated with cutting-edge technologies at world-class standards.
  • Smart Agro — Smart Agro specializes in investing and improving companies in the agro-tech fields.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Israel Medical startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series C, Venture - Series Unknown
  • Geography: Israel, United States

Investor stats

  • Total investments: 17
  • Round size: Series C $13M–$22M; Venture - Series Unknown $8M–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
  • SP Nano — SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin.
  • Raziel Therapeutics — Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 4 investments in Israel Medical startups

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 80
  • Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — raised $340M in 2022

Portfolio highlights

  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
  • Hopscotch Primary Care — We provide primary care services to seniors on Medicare, offering more time with your doctor, and a full care team to support all of your healthcare needs.
Show all investments...

Terra Venture Partners
VC Fund · Jerusalem, Yerushalayim, Israel · 3 investments in Israel Medical startups

We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies

Show more...

Investment focus

  • Industry: Software, Health Care, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 41
  • Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $9.6M in 2021

Portfolio highlights

  • ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
  • Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
  • Intuition Robotics — The AI care companion robot for older adults
Show all investments...

Robin Hood Ventures
VC Fund · Philadelphia, Pennsylvania, United States · 3 investments in Israel Medical startups

Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Convertible Note
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 165
  • Round size: Seed $210k–$4.3M; Series A $180k–$11M; Convertible Note $26k–$560k
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Aseon Labs — Robotic pitstops for self driving cars. A depot in a box for charging, cleaning & inspecting AVs directly in operating zones. Backed by @ycombinator
  • Cooler Heads — Cooler Heads develops cold caps designed for chemotherapy patients.
  • Surface Design Solutions — Surface Design Solutions uses physics-informed AI to help manufacturers reduce scrap, improve yield, and diagnose costly surface performance issues.
Show all investments...

ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series C, Venture - Series Unknown
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Round size: Series A $4.4M–$17M; Series C $30M–$55M; Venture - Series Unknown $11M–$105M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Show all investments...

Neo Ventures
VC Fund · Sofia, Grad Sofiya, Bulgaria · 3 investments in Israel Medical startups

Neo Ventures is a venture capital investment platform focused on deep tech, funds and high-growth startup portfolio.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 20
  • Round size: Seed $500k–$2.9M; Series A $2.3M–$24M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
  • Convex — All gas, no breakages. Convex is the reactive backend platform that keeps up with you and your agents.
  • Extend Robotics — Extend Human Capabilities Beyond Physical Presence
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 18
  • Round size: Series A $4M–$55M; Series B $15M–$40M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 3 investments in Israel Medical startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 727
  • Round size: Series A $9.8M–$140M; Series B $24M–$148M; Series C $19M–$160M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $192M in 2026

Portfolio highlights

  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
  • Insilico Medicine — Artificial Intelligence for Drug Discovery and Aging Research
Show all investments...

Elron Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

Show more...

Investment focus

  • Industry: Information Technology, Software, Cyber Security
  • Stage:Series A, Seed
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 66
  • Round size: Seed $1.5M–$15M; Series A $1M–$17M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • CartiHeal — Target improved outcomes in the treatment of knee cartilage and osteochondral defects with a porous, biocompatible and biodegradable off-the-shelf implant.
  • Brainsgate — BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developedthe ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to dental treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.
  • Raven.io — Secure apps with our Runtime Protection Platform. De-prioritize 99% of vulnerabilities with runtime reachability and prevent exploits, zero-days and supply chain attacks with intelligent, library-level policies.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
TechWald Holding S.p.A.
VC Fund · Milan, Lombardia, Italy · 3 investments in Israel Medical startups

TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 10
  • Round size: Series A $3.6M–$7.1M; Series B $8.5M–$48M; Series C $9.3M–$60M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
  • RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
  • Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Show all investments...

Qure Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Israel Medical startups

Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel

Investor stats

  • Total investments: 9
  • Round size: Series A $8.8M–$20M; Series B $20M–$20M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • CoreMap — CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
  • Sweetch — Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized precision engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale.
  • Carevive Systems — Powered by real world patient experience data, Carevive builds cancer care management tools that improve patient quality of life and survival outcomes.
Show all investments...

MTIP AG
VC Fund · Basel, Basel-Stadt, Switzerland · 3 investments in Israel Medical startups

MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!

Show more...

Investment focus

  • Industry: Health Care, Medical, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Spain

Investor stats

  • Total investments: 29
  • Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: Likely still investing — raised $250M in 2021

Portfolio highlights

  • TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
  • Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
  • NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Show all investments...

Insight Partners
VC Fund · New York, New York, United States · 3 investments in Israel Medical startups

Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, Germany

Investor stats

  • Total investments: 1371
  • Round size: Series A $12M–$70M; Series B $18M–$111M; Series C $25M–$140M
  • Lead/follow: 68% lead, 32% follow
  • Last fund: Likely actively investing — fresh fund, raised $13B in 2025

Portfolio highlights

  • Bionexo — Bionexo develops and operates high-performance digital solutions for hospital supply chains.
  • FloVision Solutions — Food Analytics to maximize profits and minimize waste. FloWaste allows food service providers to optimize meal preparation, ingredient combinations, and portion sizing
  • In-Fusio — With the largest market share of mobile games in Europe and China and rapidly expanding presence in the U.S., IN-FUSIO offers a diverse portfolio of games, entertainment and value added services to wireless carriers. At present, IN-FUSIO's 65 mobile titles have been enjoyed by 11 million players worldwide. From stand-alone Java(TM), BREW andi-mode (Doja) games to a fully managed and integrated games service, (ExEn, ExEn Gaming Extensions EGE for Java MIPD 2.0) IN-FUSIO has unparalleled industry experience. As a games publisher and game service provider, IN-FUSIO is a clear entry point for brands and game developers to effortlessly enter the mobile market.IN-FUSIO customers include Verizon, Sprint, AT&T, Vodafone D2, Orange France, SFR, Orange UK, Vodafone Omnitel, Telefonica Moviles and China Mobile. The company currently has offices in Los Angeles, Chicago, London, Bordeaux, Moscow and Shanghai.
Show all investments...

ShengJing360
VC Fund · Beijing, Beijing, China · 3 investments in Israel Medical startups

Shengjing Group offers businesses consulting services.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Manufacturing, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, Israel, Malaysia

Investor stats

  • Total investments: 43
  • Round size: Seed $2M–$14M; Series A $1.9M–$40M; Series B $2.9M–$42M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Mojie — Mojie is a technology company that engages in the research and development of optics and AI solutions, known for its extensive development of various core technologies. The company operates research and development offices and high-end manufacturing bases.
  • Tanwei Xinlian — Tanwei Xinlian serves as a domestic provider of interconnection communication solutions, offering expertise and innovation in this field.
  • Fengxun Biotech — Nantong Fengxun Bio is a medical testing service provider. Its primary business focus is on testing services, cell technology research and development, and human stem cell technology development and application, among other things.
Show all investments...

Alon Medtech Ventures
VC Fund · Yoqne`am `illit, HaZafon, Israel · 3 investments in Israel Medical startups

Alon MedTech Ventures is active in the initiation and growth of young high-tech companies in the medical device arena. They seek to make a difference: Alon MedTech is engaged with novel technologies that improve human well-being and quality of life.Owned by leading Israeli Entrepreneur Dr Shimon Eckhouse, Alon MedTech is backed by a powerfullegacy. Dr Eckhouse has founded and invested in numerous medical technology firms, two of which are leading international companies, (ESC Medical [Lumenis] and Syneron Medical), both traded on NASDAQ.Their experience, professionalism, wide network and solid financial resources enable them to provide their companies with distinctive sponsorship. This includes such key factors as technological and managerial guidance, strategic counseling and fundraising.The objective of this private incubator is to accompany young ventures through all stages, from lab to marketplace – and beyond. From conceptualization of product through to company success, their assistance can extend for years after a company is up and running.Alon MedTech couples the highest levels of technological knowhow with long years of business acumen. The result: a rich and fertile environment for growing successful companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Medical Device
  • Stage:Seed, Series B, Corporate Round
  • Geography: Israel

Investor stats

  • Total investments: 5
  • Round size: Seed $900k–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
  • Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
  • Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
Show all investments...

Mindset Ventures
VC Fund · São Paulo, Sao Paulo, Brazil · 3 investments in Israel Medical startups, 8 in the past 12 months

Mindset Ventures is an early-stage VC firm that supports entrepreneurs in their growth and international expansion. The firm targets B2B startups technology applied to Agriculture, Financial Services, Healthcare, Cybersecurity, Education, and Enterprise Software industry. It was founded in 2016 and headquartered in Sao Paulo, Brazil.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 112
  • Round size: Seed $1.9M–$14M; Series A $5.5M–$30M; Series B $6.8M–$35M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2019

Portfolio highlights

  • Alta — Alta leverages data and AI to drive business growth 24/7.
  • Belo — Crypto for everyone, everyday
  • Mogul — Your path to financial success in the music business.
Show all investments...

EISMEA
VC Fund · 3 investments in Israel Medical startups

Investment focus

  • Industry: Manufacturing, Biotechnology, Software
  • Stage:Grant, Venture - Series Unknown, Seed
  • Geography: Spain, Italy, United Kingdom

Investor stats

  • Total investments: 2435
  • Round size: Seed $52k–$1.1M; Grant $54k–$2.1M; Venture - Series Unknown $573k–$2.6M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
  • BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
  • Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Show all investments...

XTX Ventures
VC Fund · London, England, United Kingdom · 3 investments in Israel Medical startups

XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 96
  • Round size: Seed $2M–$7.6M; Series A $6M–$60M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: Likely still investing — raised $9.6M in 2024

Portfolio highlights

  • Jenesys AI — Meet Jack, your AI-powered bookkeeping agent, automates line-item extraction, GL coding, and bank reconciliation with real-time insights.
  • Qureight — Pioneering data curation to solve complex diseases
  • Proxima Fusion — We are a European fusion energy startup pursuing the clearest path to grid deployment.
Show all investments...

Connecticut Innovations
VC Fund · Rocky Hill, Connecticut, United States · 3 investments in Israel Medical startups

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 292
  • Round size: Seed $150k–$5.3M; Series A $2.1M–$25M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $50M in 2023

Portfolio highlights

  • eBrevia — Analyze contracts at scale, extract key data, and identify risk with eBrevia. Draft and redline agreements in Microsoft Word with DraftPro.
  • Mobile Sense — The traditional diagnostic market is being transformed by advances in high performance wearables. This seismic shift led by consumer products which are uncovering new patients who previously went undetected, but still require a detailed diagnosis. Mobile Sense™ is building foundational technology that enables this transformation throughoff-the-chest wearables for long term management of cardiac arrhythmias. Developed over 7 years with $4.2M in grant funding and $1.3M in seed funding, Mobile Sense™ has a platform for differentiated wearables. Our embedded algorithms coupled with non-adhesive, wireless & waterproof sensors provides high fidelity continuous ECG and PPG recordings. The automatic monitoring provides 24/7, 365 days/yr continuous detection and classification of dangerous heart arrhythmias.
  • NovaTract Surgical — NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ziegler Meditech Equity Partners
VC Fund · Milwaukee, Wisconsin, United States · 3 investments in Israel Medical startups

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Mobile
  • Stage:Series C, Series E, Series F
  • Geography: United States, Israel

Investor stats

  • Total investments: 6
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $26M in 2014

Portfolio highlights

  • Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
  • MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
  • MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Show all investments...

Technion - Israel Institute of Technology
VC Fund · Haifa, Hefa, Israel · 3 investments in Israel Medical startups

“Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.

Show more...

Investment focus

  • Industry: Medical, Health Care, Therapeutics
  • Stage:Seed, Grant, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 8
  • Round size: Seed $1.2M–$20M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Mana.bio — Mana.bio is an AI based drug delivery startup, focusing on gene therapy including RNA and DNA-based therapeutics and vaccines
  • ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.
  • Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
Show all investments...

Tal Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Israel, United States, Cyprus

Investor stats

  • Total investments: 59
  • Round size: Seed $3M–$12M; Pre-Seed $2.1M–$4M; Series A $5M–$25M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: Likely still investing — raised $4.7M in 2022

Portfolio highlights

  • TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
  • Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
  • Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Show all investments...

CE Ventures (CEIIF)
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 3 investments in Israel Medical startups

CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.

Show more...

Investment focus

  • Industry: Software, Analytics, Big Data
  • Stage:Series B, Series A, Series C
  • Geography: Israel, United States, India

Investor stats

  • Total investments: 34
  • Round size: Series A $4M–$7M; Series B $3.5M–$30M; Series C $10M–$40M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2016

Portfolio highlights

  • DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
  • NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
  • Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
Show all investments...

Entrée Capital
VC Fund · London, England, United Kingdom · 3 investments in Israel Medical startups

We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 297
  • Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $17M–$54M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $175M in 2025

Portfolio highlights

  • Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
  • Identiq — Identiq's network members fight fraud and improve user experience by validating new users and vouching for ones they already know without sharing any personal user data at all.
  • Horizon Trade — The first agentic trading platform Type your strategy in plain English, backtest, deploy live Backed by @EntreeCapitalVC
Show all investments...

Alumni Ventures
VC Fund · Manchester, New Hampshire, United States · 3 investments in Israel Medical startups

Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 2682
  • Round size: Seed $880k–$9.9M; Series A $3.5M–$32M; Series B $8M–$75M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: Likely actively investing — fresh fund, raised $90k in 2026

Portfolio highlights

  • LOLIWARE — LOLIWARE is rewriting the story of destructive packaging. By harnessing the power of seaweed to replace plastic at scale, LOLIWARE is tapping into its potential to regenerate our ocean and decarbonize our planet.
  • Talk Local — Need a service professional? Search the Nation's #1 Service Directory. It's Free and Fast, get connected over the phone instantly with Local Plumbers, Accountants, Computer Repair Pros, Dentists, Heating & Cooling HVAC, and other service professionals!
  • HopSkipDrive — Arranging safe, dependable transportation or children ages 6+ with qualified caregivers
Show all investments...

Good Company
VC Fund · Tel Aviv, Tel Aviv, Israel · 3 investments in Israel Medical startups

Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Recruiting
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 20
  • Round size: Seed $700k–$22M; Pre-Seed $400k–$4.8M; Series A $5M–$17M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: Likely still investing — raised $30M in 2023

Portfolio highlights

  • Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
  • TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
  • Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
Show all investments...

DEFTA Partners
VC Fund · San Francisco, California, United States · 2 investments in Israel Medical startups

DEFTA Partners is a venture capital firm focusing on technology. They primarily make seed and first round investments in early stage information technology companies with global opportunities to accelerate growth. DEFTA has offices and partners in the United States, Japan, Israel and the United Kingdom. via: DEFTA Partners

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Israel, Japan

Investor stats

  • Total investments: 32
  • Round size: Series A $2.5M–$13M; Series B $6.5M–$47M; Venture - Series Unknown $989k–$20M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $63M in 2019

Portfolio highlights

  • Fortinet — Fortinet secures the largest enterprise, SMB, service provider, and government organizations around the world. Secure your network today and into the future.
  • 1World Online — We believe it's important for everyone to know what people really think about today's social issues
  • Endogena — Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs. Endogena's approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.The company implements innovation in the field of regenerative medicine. Their sciencecombines the latest developments in stem cell biology, AI, and expertise in small-molecule drug design to develop breakthrough treatments for degenerative diseases.
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Israel Medical startups, 7 in the past 12 months

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 44
  • Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Kimba — Kimba is the first sleep system that reads your body and responds to it silently and automatically every night, using the only sensory pathway that can reach a sleeping brain. Reserve your Kimba today!
  • CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
  • Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
Show all investments...

HealthpointCapital
VC Fund · New York, New York, United States · 2 investments in Israel Medical startups

HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Manufacturing
  • Stage:Series B, Series C
  • Geography: Israel, United States

Investor stats

  • Total investments: 7
  • Round size: Series B $5M–$13M; Series C $12M–$15M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
  • OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Israel Healthcare Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Israel HealthCare Ventures (IHCV) - a leading Israeli life sciences venture fund - was founded at the end of the year 2000. The fund is focused on providing funds (capital) to Israeli and Israeli-related companies in the fields of medical devices, pharmaceuticals, biotechnology, nanotechnology and medical-related IT.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series D, Series F
  • Geography: Israel, United States

Investor stats

  • Total investments: 8
  • Round size: Series D $1.2M–$16M; Series F $19M–$40M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • OrSense — OrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood parameters. OrSense's NBM-200MP monitors and displays oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram andhemoglobin, all non-invasively and continuously. The system is designed for use in hospitals including operating and recovery rooms and intensive care units as well as in outpatient sites and emergency services. OrSense's non-invasive hemoglobin/hematocrit monitor was granted the CE approval and was tested on over 4,000 patients and donors at 15 sites in the U.S. and Europe. The Company's products are based on its proprietary Occlusion Spectroscopy technology, which overcomes key obstacles that hinder the performance of competing approaches.
  • Gamida Cell — Gamida Cell is dedicated to making a significant difference in the clinical practice of modern medicine by first creating, then tapping the regenerative power of therapeutic stem cells. Gamida Cell is a leader in the development of stem cell therapy technologies and products. The therapies are based on expanded populations of cord blood stem cells,for the treatment of illnesses with significant unmet clinical needs such as blood cancers, autoimmune and metabolic diseases as well as neutropenia.
  • Lifeward — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.
Show all investments...

GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Israel Medical startups

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Industry: Software, Health Care, Cyber Security
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 35
  • Round size: Seed $1M–$9M; Series A $1.5M–$9M; Series B $100k–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
  • Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Show all investments...

Smith & Nephew
VC Fund · London, England, United Kingdom · 2 investments in Israel Medical startups

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 5
  • Round size: Series B $2.7M–$30M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
  • Trice Medical — Perform a full diagnostic arthroscopy on an HD tablet thanks to the mi-eye 2. Get mi-eye 2 for your doctor's office today.
  • Miach Orthopaedics — Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts.
Show all investments...

Arc Impact
VC Fund · Haifa, Hefa, Israel · 2 investments in Israel Medical startups

Arc Impact is a venture capital firm.

Show more...

Investment focus

  • Industry: Health Care, Food and Beverage, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 10
  • Round size: Seed $2M–$6.2M; Series A $10M–$20M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MDI Health — Transform Quality Metrics Clinical Outcomes & Costs all inOne Platform. Your AI Co-Pilot for Medication Management
  • MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
  • 50CUT — Mush Foods is an Israeli-based food tech company, growing edible mushroom mycelium to create innovative and sustainable animal-free protein as an ingredient for the food and beverage industry. We harness the fantastic power and innate intelligence of mushrooms to face future global challenges and provide sustainable groundbreaking food solutions tothe food of the future.
Show all investments...

Group 11
VC Fund · Beverly Hills, California, United States · 2 investments in Israel Medical startups

Group 11 invests in visionary entrepreneurs who are utilizing the unstoppable momentum of AI and FinTech to redraw the landscape of their respective industries. With a goal of creating change across generations and building long term value through technology, Group 11 has emerged as a coveted partner to veteran entrepreneurs at the forefront oftheir fields. Since its inception in 2012, the firm has deployed over $600 million across six funds in some of the world’s most prominent and disruptive technology companies, including: Tipalti, Navan, Next Insurance, HomeLight, Sunbit, Masterschool, Healthee, Dream, and BridgeWise.

Show more...

Investment focus

  • Industry: FinTech, Software, Financial Services
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel

Investor stats

  • Total investments: 83
  • Round size: Seed $1.5M–$22M; Series A $6M–$34M; Series B $11M–$100M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — raised $100M in 2022

Portfolio highlights

  • Venn — Venn creates a new way of urban neighboring by managing homes, creating shared spaces, supporting hyperlocal business initiatives and services, programs events, and facilitating community engagement – all on a neighborhood-wide level. Operating by the motto, “If they build it, they will stay,” venn’s platform encourages urbanites to become activecreators and participants in the development of their community and enables developing neighborhoods to become as vibrant and desirable as the downtown core. Founded in 2016 by people raised in the Big City and in cooperative communities, venn is a new movement of neighboring that impacts tens of thousands of people in three cities (Tel Aviv, Brooklyn, and Berlin) with +75 employees
  • Healthee — Healthee provides an AI-driven platform designed to simplify health benefits navigation for employees and employers. The platform includes a plan comparison tool that assists employees in evaluating and selecting health plans based on individual or family needs. This tool utilizes self-reported health information to provide tailoredrecommendations, streamlining the open enrollment process. Healthee also offers wellness tracking features, enabling users to monitor essential health milestones such as annual physicals, dental exams, and vision appointments. This functionality supports preventive care and encourages proactive health management.
  • Dream — Dream Security provides critical infrastructure defensive cyber solutions.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 2 investments in Israel Medical startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 28
  • Lead/follow: no public data

Portfolio highlights

  • Easy Rain — We are Easyrain. Continuous innovation runs in our blood.With our expertise, we develop, simulate, and test solutions, launching our ideas into production. We exploit the basic laws of physics to engineer a tangible solution!
  • Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
  • Alia Therapeutics — Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Show all investments...

Binder & Partners Ventures
VC Fund · Paris, Ile-de-France, France · 2 investments in Israel Medical startups

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

Show more...

Investment focus

  • Industry: Software, Information Technology, Computer
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, France, United States

Investor stats

  • Total investments: 16
  • Round size: Seed $2M–$5M; Series A $8M–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Acsense — The enterprise IAM Resilience Platform offering backup and recovery to reduce the risk of downtime, maintain data integrity, and deliver seamless access.
  • CYREBRO — CYREBRO is your online centralized interactive SOC platform that integrates all your security events with strategic monitoring, threat intelligence and IR
  • Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
Show all investments...

Flerie Invest
VC Fund · 2 investments in Israel Medical startups

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Sweden, United States, United Kingdom

Investor stats

  • Total investments: 24
  • Round size: Series A $2.5M–$23M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
  • Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Show all investments...

Rimonci Capital
VC Fund · 2 investments in Israel Medical startups

A dedicated to China-Israel cross border investment.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Israel

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
  • EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
  • BELKIN Vision — Imagine an efficient, non-contact glaucoma laser treatment able to alleviate IOP painlessly. Accessible Glaucoma Care at the touch of a button.
Show all investments...

Yozma Group
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Israel Medical startups

Yozma earned worldwide recognition as the founder of Israel's VC industry.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Series B, Seed
  • Geography: Israel, United States, South Korea

Investor stats

  • Total investments: 28
  • Round size: Seed $400k–$4.5M; Series B $2.5M–$59M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • BiSiChem — Invent targeted small molecule drugs that are either first-in-class or second-generation
  • RoomGenie — An AI-powered chatbot for hotels revolutionizes the way guests interact with in-room services by enabling seamless cross-selling and upselling. Integrated within smart devices or hotel apps, this AI solution leverages natural language processing (NLP) to communicate with guests in a conversational and personalized manner.From booking spatreatments and restaurant reservations to upgrading rooms or scheduling late checkouts, the chatbot intuitively identifies guest preferences and suggests relevant services. It analyzes data such as guest profiles, previous stays, and real-time behavior to deliver tailored recommendations, boosting both guest satisfaction and revenue.Available 24/7, the chatbot ensures instant responses to guest inquiries, reducing dependence on front-desk staff and enhancing operational efficiency. Additionally, it supports multiple languages, catering to a global clientele and making communication barrier-free. Hotels can integrate the AI chatbot with their property management systems (PMS) and point-of-sale (POS) platforms to streamline service delivery and track guest interactions.The solution empowers hotels to provide a hyper-personalized, tech-forward experience, which appeals to modern travelers. By automating cross-selling and upselling opportunities while improving guest engagement, the chatbot not only enhances the overall stay experience but also drives incremental revenue, making it a vital tool for the hospitality industry.
  • Meat.The End — MTE revolutionizes food production to create desired textures and provides a solution for food companies, by developing novel ingredients and technological solutions that enhance the texture properties of alternative protein products.
Show all investments...

Medical VC funding in Israel at a glance

Stats across 572 deals from 577 investors.

577
investors
in Israel Medical startups
572
deals
in Israel Medical startups
$4.3M
median round
in Israel Medical startups
40%
lead investors
lead at least one round
16%
Seed
most common funding stage

Access all 577 VC funds in Israel Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Israel investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 577 VC funds investing in Israel Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists